The CDC Won’t Give the Public a Full Picture of Fertility Treatment Risks
By Jackie Davalos, Rachel Adams-Heard, and Kendall Taggart,
Bloomberg
| 01. 24. 2025
For women in the US seeking fertility treatment or considering donating their eggs, there’s a fair amount of information they can find about any given clinic or hospital. They might look for data on how many egg retrievals the clinic has done or the ages of its patients. Many times they’ll want to know how often treatment resulted in the birth of a baby.
But one thing they won’t be able to find out is how often the procedure has gone wrong. That’s because while the Centers for Disease Control and Prevention discloses “success rates,” it keeps information about health complications under lock and key.
The data gap is particularly troubling at a time when fertility treatment is increasingly relying on eggs from donors. As egg-freezing technology has advanced, the number of in vitro fertilization cycles using donor eggs has grown more than 170% since 2000, catapulting the egg-banking and donation sector into a $2 billion business in the US, according to investment firm Harris Williams. In December, Bloomberg Businessweek chronicled how a burgeoning global market for human eggs can lead...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...
By Hannah Devlin, The Guardian | 07.05.2025
Scientists are just a few years from creating viable human sex cells in the lab, according to an internationally renowned pioneer of the field, who says the advance could open up biology-defying possibilities for reproduction.
Speaking to the Guardian, Prof...